drugset / Trial / NCT05705804

Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial

NCT05705804

Recruiting 250 enrolled Yonsei University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study was to investigate the effect of pitavastatin or pitavastatin and ezetimibe combination therapy on glucose metabolism compared to atorvastatin in patients with atherosclerotic cardiovascular disease with metabolic syndrome.

Timeline

Start
2023-06-13
Primary completion
2027-05-01
Completion
2027-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 40 mg
Subject Ezetemibe Unknown 10 mg
Subject Pitavastatin Small molecule 4 mg